Evidence map›Paper›PMID 28928464›Full record

ArticleScientific reports2017

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.

Jana Zeitvogel, Neele Jokmin, Samira Rieker, Ilona Klug, Christina Brandenberger, Thomas Werfel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Use of 2D and 3D cell cultures in dermatology].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jana ZeitvogelDivision of Immunodermatology and Allergy Research, Department for Dermatology, Allergy and Venereology, Hannover Medical School, 30625, Hannover, Germany. Zeitvogel.Jana@MH-Hannover.de.
Neele JokminDivision of Immunodermatology and Allergy Research, Department for Dermatology, Allergy and Venereology, Hannover Medical School, 30625, Hannover, Germany.
Samira RiekerDivision of Immunodermatology and Allergy Research, Department for Dermatology, Allergy and Venereology, Hannover Medical School, 30625, Hannover, Germany.
Ilona KlugDivision of Immunodermatology and Allergy Research, Department for Dermatology, Allergy and Venereology, Hannover Medical School, 30625, Hannover, Germany.
Christina BrandenbergerInstitute of Functional and Applied Anatomy, Hannover Medical School, 30625, Hannover, Germany.
Thomas WerfelDivision of Immunodermatology and Allergy Research, Department for Dermatology, Allergy and Venereology, Hannover Medical School, 30625, Hannover, Germany.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GATA3 is a transcription factor with an important role in atopic diseases because of its role in the differentiation of Th2 lymphocytes. Moreover, GATA3 is expressed in keratinocytes and has a role in keratinocyte differentiation and the establishment of the epidermal barrier. In this study, we investigated the role of GATA3 in keratinocytes in the context of epidermal barrier integrity under inflammatory skin conditions. When analysing skin samples from atopic dermatitis and psoriasis patients or healthy controls, we detected decreased expression of GATA3 in the stratum spinosum and stratum granulosum of atopic dermatitis and psoriasis patients when compared to healthy controls. Our cell cultures experiments revealed that a downregulation in GATA3 by shRNA leads to a significant reduction of filaggrin mRNA under atopic dermatitis-like conditions in keratinocytes. Overexpression of GATA3 in keratinocytes reversed this effect and significantly upregulated filaggrin and, furthermore, filaggrin-2 mRNA expression. Our results demonstrate that GATA3 is involved in the regulation of filaggrin and filaggrin-2 expression during inflammatory conditions in the skin. Thus, GATA3 may be of special importance for the establishment and maintenance of an intact epidermal barrier, especially in atopic dermatitis.

Indexed as

Gene Expression RegulationCells, CulturedDermatitis, AtopicFemaleFilaggrin ProteinsGATA3 Transcription FactorHumansIntermediate Filament ProteinsKeratinocytesMaleRNA, MessengerS100 ProteinsFilaggrin ProteinsFLG2 protein, humanFLG protein, humanGATA3 protein, humanGATA3 Transcription FactorIntermediate Filament ProteinsRNA, MessengerS100 Proteins

Identifiers

PMID28928464
PMCPMC5605628
OpenAlexW2754691730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.